Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells

[1]  F. Khuri,et al.  Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells , 2015, Oncogene.

[2]  S. Green,et al.  Discovery of (R)-8-(1-(3,5-difluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide (AZD8186): a potent and selective inhibitor of PI3Kβ and PI3Kδ for the treatment of PTEN-deficient cancers. , 2015, Journal of medicinal chemistry.

[3]  J. Nylandsted,et al.  Methods for the quantification of lysosomal membrane permeabilization: a hallmark of lysosomal cell death. , 2015, Methods in cell biology.

[4]  John A. Tallarico,et al.  Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo , 2014, Nature Cell Biology.

[5]  L. Rénia,et al.  Validation of a chloroquine-induced cell death mechanism for clinical use against malaria , 2014, Cell Death and Disease.

[6]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.

[7]  K. Webster,et al.  Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis , 2013, Oncotarget.

[8]  D. Klionsky,et al.  The machinery of macroautophagy , 2013, Cell Research.

[9]  The Cancer Genome Atlas Research Network,et al.  Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.

[10]  Amy Y. M. Au,et al.  p53 status determines the role of autophagy in pancreatic tumour development , 2013, Nature.

[11]  Z. Huang,et al.  Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment , 2013, Cell Death and Disease.

[12]  E. Cuyás,et al.  The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer , 2013, Scientific Reports.

[13]  S. Fulda,et al.  The dual PI3K/mTOR inhibitor NVP‐BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial‐lysosomal cross‐talk , 2013, International journal of cancer.

[14]  R. Perez-soler,et al.  The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  T. P. Neufeld,et al.  ULK1 induces autophagy by phosphorylating Beclin-1 and activating Vps34 lipid kinase , 2013, Nature Cell Biology.

[16]  Linette Ruston,et al.  Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014. , 2013, Bioorganic & medicinal chemistry letters.

[17]  M. Knowles,et al.  Oncogenic FGFR3 gene fusions in bladder cancer , 2012, Human molecular genetics.

[18]  M. Gleave,et al.  Blocked Autophagy Using Lysosomotropic Agents Sensitizes Resistant Prostate Tumor Cells to the Novel Akt Inhibitor AZD5363 , 2012, Clinical Cancer Research.

[19]  A. Vollmar,et al.  Mode of Cell Death Induction by Pharmacological Vacuolar H+-ATPase (V-ATPase) Inhibition* , 2012, The Journal of Biological Chemistry.

[20]  P. Saftig,et al.  Sensitivity to Lysosome-Dependent Cell Death Is Directly Regulated by Lysosomal Cholesterol Content , 2012, PloS one.

[21]  Jinfeng Liu,et al.  FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth. , 2012, Cancer research.

[22]  C. Kraft,et al.  Mechanism and functions of membrane binding by the Atg5–Atg12/Atg16 complex during autophagosome formation , 2012, The EMBO journal.

[23]  Ronald M. Krauss,et al.  RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin , 2012, PLoS genetics.

[24]  C. Dinney,et al.  Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells , 2012, Cancer biology & therapy.

[25]  Andrew P Thomas,et al.  AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. , 2012, Cancer research.

[26]  Jing Li,et al.  Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background , 2012, Molecular Cancer Therapeutics.

[27]  F. Khuri,et al.  Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagy , 2011, Cancer biology & therapy.

[28]  K. Shokat,et al.  The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile , 2011, Proceedings of the National Academy of Sciences.

[29]  Jin Ye,et al.  Regulation of cholesterol and fatty acid synthesis. , 2011, Cold Spring Harbor perspectives in biology.

[30]  K. Shokat,et al.  Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K—mTOR pathway in pancreatic adenocarcinoma , 2011, Journal of Molecular Medicine.

[31]  C. Pan,et al.  Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder , 2011, Histopathology.

[32]  B. Manning,et al.  Transcriptional control of cellular metabolism by mTOR signaling. , 2011, Cancer research.

[33]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[34]  H. Coller,et al.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. , 2011, Genes & development.

[35]  C. James,et al.  Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma , 2010, Science Signaling.

[36]  K. Öllinger,et al.  Regulation of apoptosis-associated lysosomal membrane permeabilization , 2010, Apoptosis.

[37]  Xue-Ru Wu.  Biology of urothelial tumorigenesis: insights from genetically engineered mice , 2009, Cancer and Metastasis Reviews.

[38]  She Chen,et al.  ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy* , 2009, Journal of Biological Chemistry.

[39]  R A Knight,et al.  Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes , 2009, Cell Death and Differentiation.

[40]  J. Guan,et al.  Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. , 2009, Molecular biology of the cell.

[41]  C. Jung,et al.  ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. , 2009, Molecular biology of the cell.

[42]  C. Cordon-Cardo,et al.  Inactivation of p53 and Pten promotes invasive bladder cancer. , 2009, Genes & development.

[43]  Mitsuru Nenoi,et al.  Regulation of , 2004 .

[44]  Shu-Jing Hao,et al.  Loss of membrane cholesterol affects lysosomal osmotic stability. , 2008, General physiology and biophysics.

[45]  David P. Davis,et al.  Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents , 2008, The Journal of cell biology.

[46]  Elina Ikonen,et al.  Cellular cholesterol trafficking and compartmentalization , 2008, Nature Reviews Molecular Cell Biology.

[47]  J. Estaquier,et al.  Commitment to Apoptosis in CD4+ T Lymphocytes Productively Infected with Human Immunodeficiency Virus Type 1 Is Initiated by Lysosomal Membrane Permeabilization, Itself Induced by the Isolated Expression of the Viral Protein Nef , 2007, Journal of Virology.

[48]  G. Evan,et al.  Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. , 2007, The Journal of clinical investigation.

[49]  I. Tannock,et al.  Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration , 2006, British Journal of Cancer.

[50]  G. Kroemer,et al.  Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine , 2003, Oncogene.

[51]  G. Lalmanach,et al.  CA-074, But Not Its Methyl Ester CA-074Me, Is a Selective Inhibitor of Cathepsin B within Living Cells , 2002, Biological chemistry.

[52]  B. Roth,et al.  The discovery and development of atorvastatin, a potent novel hypolipidemic agent. , 2002, Progress in medicinal chemistry.

[53]  L. Ellerby,et al.  Lysosomal Protease Pathways to Apoptosis , 2001, The Journal of Biological Chemistry.

[54]  Takeshi Noda,et al.  A ubiquitin-like system mediates protein lipidation , 2000, Nature.

[55]  Michael D. George,et al.  A protein conjugation system essential for autophagy , 1998, Nature.

[56]  M C Phillips,et al.  Use of cyclodextrins for manipulating cellular cholesterol content. , 1997, Journal of lipid research.

[57]  E. Becker,et al.  Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d. , 1989, Biochemical and biophysical research communications.

[58]  K. Imahori,et al.  Thiol protease-specific inhibitor E-64 arrests human epidermoid carcinoma A431 cells at mitotic metaphase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Ohkuma,et al.  Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages , 1981, The Journal of cell biology.